Avian Flu and Emergency Preparedness
November 2005
BNA's Web Watch is prepared by Laura
Gordon-Murnane. E-mail suggestions for future weekly topics
always welcome.
Federal Government
White House
Office of Management and Budget
Estimate
No. 15, Nov. 1, 2005 - Budget Requests to Deal with Possible Avian
Flu Pandemic
Pending Congressional Legislation
H.R.4131
Title: To amend title 35, United States Code, to provide for compulsory
licensing of certain patented inventions relating to health care
emergencies, and to provide that applications under section 505
of the Federal Food, Drug, and Cosmetic Act that are submitted pursuant
to such licenses may be approved with immediate effective dates.
Congressional Hearings
Senate Committee on Foreign Relations
Avian
Influenza - Are We Prepared? (Audio File of Hearing)
Presiding: Senator Lugar
Senator
Lugar's Opening Statement
Senator
Biden's Opening Statement
Witnesses:
Panel 1
The
Honorable Paula J. Dobriansky - Department of State Under Secretary
for Democracy and Global Affairs
Dr.
Anthony S. Fauci – Director - Department of Health and
Human Services - National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Dr.
Julie Gerberding Director - Department of Health and Human
Services - Centers for Disease Control and Prevention
The
Honorable Andrew S. Natsios – Administrator - U.S. Agency
for International Development
Panel 2
Laurie
Garrett - Senior Fellow for Global Health - Council on Foreign
Relations
James
Newcomb - Managing Director of Research - Bio-Economic
Research Associates
Committee on Energy and Commerce
Assessing the National Pandemic Flu Preparedness Plan (November
8, 2005)
Panel 1
The
Honorable Michael O. Leavitt - Secretary U.S. Department of
Health and Human Services
Testimony
of Thomas R. Frieden, M.D., M.P.H. - Commissioner of Health
New York City Department of Health and Mental Hygiene
(November 8, 2005)
House Committee on Government Reform
The National Pandemic Influenza Preparedness and Response Plan Is
the U.S. Ready for Avian Flu? (Nov 04, 2005)
Opening Statement
Chairman
Davis' Opening Statement
Henry
Waxman Statement on Administration’s Flu Plan
(November 4, 2005)
Rep. Henry A. Waxman Committee On Government Reform U.S. House
Of Representatives (October 14, 2005)
The
Administration’s Preparation for Avian Flu
Witness Testimony
Testimony
of the Honorable Michael O. Leavitt, Secretary, U.S. Department
of Health and Human Services
Testimony
of Thomas R. Frieden, M.D., M.P.H. Commissioner of Health
New York City Department of Health and Mental Hygiene (November
4, 2005)
Full Committee Hearing on U.S. Readiness for the Next Flu
Pandemic (June 30, 2005)
Opening Statement
Chairman
Davis' Opening Statement
Witness Testimony
Testimony
of James W. LeDuc, Ph.D., Director, Division of Viral and Rickettsial
Diseases, National Center for Infectious Diseases, Centers for Disease
Control and Prevention, U.S. Department of Health and Human Services
Testimony
of Anthony S. Fauci, M.D., Director, National Institute of Allergy
and Infectious Diseases, National Institutes of Health, U.S. Department
of Health and Human Services
Testimony
of Bruce G. Gellin, M.D., M.P.H., Director, National Vaccine
Program Office, Office of Public Health and Science, Office of the
Assistant Secretary for Health, U.S. Department of Health and Human
Services
Testimony
of Ms. Marcia Crosse, Director, Health Care, U.S. Government
Accountability Office
Testimony
of Ms. Mary C. Selecky, Secretary of Health, State of Washington,
on behalf of the Association of State and Territorial Health Officials
Testimony
of Shelley Hearne, Ph.D., Executive Director, Trust for America's
Health
Testimony
of John F. Milligan, Ph.D., Executive Vice President and Chief
Financial Officer, Gilead Sciences, Inc.
Testimony
of Mr. George B. Abercrombie, President and Chief Executive
Officer, Hoffmann-La Roche, Inc., accompanied by Dr. Dominick Iacuzio,
Medical Director, Roche Laboratories, Inc.
GAO Reports – Congressional Hearings
INFLUENZA VACCINE
Shortages in 2004–05 Season Underscore Need for Better Preparation
Committee on Government Reform
INFLUENZA PANDEMIC
Applying Lessons
Learned from the 2004–05 Influenza Vaccine Shortage
Influenza Vaccine:
Shortages in 2004–05 Season Underscore Need for Better Preparation,
GAO-05-984 (Washington, D.C.: Sept. 30, 2005).
Influenza Pandemic:
Challenges in Preparedness and Response, GAO-05-863T (Washington,
D.C.: June 30, 2005).
CRS Reports
Pandemic Influenza: Domesti | 
